Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients

Shan Yu,1 Yan Wang,1 Xi Cheng,2 Minzhi Lv,3 Yuehong Cui,1 Wei Li,1 Yiyi Yu,1 Qian Li,1 Tianshu Liu1,4 1Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China; 2Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yu S, Wang Y, Cheng X, Lv M, Cui Y, Li W, Yu Y, Li Q, Liu T
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2020-10-01
Edice:Cancer Management and Research
Témata:
gastric cancer
gastrectomy
adjuvant chemotherapy
capecitabine
oxaliplatin
s-1
xelox
On-line přístup:https://www.dovepress.com/prognosis-of-adjuvant-sox-vs-xelox-chemotherapy-for-gastric-cancer-aft-peer-reviewed-article-CMAR
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky